These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: a joint mass spectrometry and circular dichroism investigation. Marzo T; Scaletti F; Michelucci E; Gabbiani C; Pescitelli G; Messori L; Massai L Biometals; 2015 Dec; 28(6):1079-85. PubMed ID: 26453060 [TBL] [Abstract][Full Text] [Related]
44. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands. Saad JS; Benedetti M; Natile G; Marzilli LG Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625 [TBL] [Abstract][Full Text] [Related]
45. Predicting the coordination number within copper chaperones: Atox1 as case study. Ansbacher T; Shurki A J Phys Chem B; 2012 Apr; 116(15):4425-32. PubMed ID: 22480337 [TBL] [Abstract][Full Text] [Related]
46. Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila. Hua H; Günther V; Georgiev O; Schaffner W Biometals; 2011 Jun; 24(3):445-53. PubMed ID: 21465178 [TBL] [Abstract][Full Text] [Related]
47. Interaction of anticancer drug cisplatin with guanine: density functional theory and surface-enhanced Raman spectroscopy study. Giese B; McNaughton D Biopolymers; 2003; 72(6):472-89. PubMed ID: 14587070 [TBL] [Abstract][Full Text] [Related]
48. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Gelasco A; Lippard SJ Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303 [TBL] [Abstract][Full Text] [Related]
49. Computer simulation of the interaction of Cu(I) with cys residues at the binding site of the yeast metallochaperone Cu(I)-Atx1. Dalosto SD J Phys Chem B; 2007 Mar; 111(11):2932-40. PubMed ID: 17388422 [TBL] [Abstract][Full Text] [Related]
50. Investigation of the elasticity of a cisplatin-DNA adduct via single-molecule measurements and bimodal modeling. Lee NK; Park JS; Johner A; Obukhov S; Hyon JY; Lee KJ; Hong SC Phys Rev E Stat Nonlin Soft Matter Phys; 2009 Apr; 79(4 Pt 1):041921. PubMed ID: 19518270 [TBL] [Abstract][Full Text] [Related]
51. A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry. Li L; Guo W; Wu K; Wu X; Zhao L; Zhao Y; Luo Q; Wang Y; Liu Y; Zhang Q; Wang F J Inorg Biochem; 2016 Aug; 161():99-106. PubMed ID: 27235272 [TBL] [Abstract][Full Text] [Related]
52. Interaction of classical platinum agents with the monomeric and dimeric Atox1 proteins: a molecular dynamics simulation study. Wang X; Li C; Wang Y; Chen G Int J Mol Sci; 2013 Dec; 15(1):75-99. PubMed ID: 24362578 [TBL] [Abstract][Full Text] [Related]
53. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity. Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171 [TBL] [Abstract][Full Text] [Related]
54. Tuning of copper-loop flexibility in Bacillus subtilis CopZ copper chaperone: role of conserved residues. Rodriguez-Granillo A; Wittung-Stafshede P J Phys Chem B; 2009 Feb; 113(7):1919-32. PubMed ID: 19170606 [TBL] [Abstract][Full Text] [Related]
55. Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro. Zhang X; Walke GR; Horvath I; Kumar R; Blockhuys S; Holgersson S; Walton PH; Wittung-Stafshede P Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2206905119. PubMed ID: 36067318 [TBL] [Abstract][Full Text] [Related]
56. Unbound position II in MXCXXC metallochaperone model peptides impacts metal binding mode and reactivity: Distinct similarities to whole proteins. Shoshan MS; Dekel N; Goch W; Shalev DE; Danieli T; Lebendiker M; Bal W; Tshuva EY J Inorg Biochem; 2016 Jun; 159():29-36. PubMed ID: 26901629 [TBL] [Abstract][Full Text] [Related]
58. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin. Scheeff ED; Briggs JM; Howell SB Mol Pharmacol; 1999 Sep; 56(3):633-43. PubMed ID: 10462551 [TBL] [Abstract][Full Text] [Related]
59. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180 [TBL] [Abstract][Full Text] [Related]